A B S T R A C T C57BL/6 mice immunized i.p. with alloantigen (P815 mastocytoma cells) develop cytolytically active thymus-derived (T) splenic lymphocytes. The definition of specific histamine receptor sites on effector T cells has been studied by measuring the in vitro effects of the hormone on cytolytic activity. Histamine was found to inhibit cytolysis reversibly and to increase lynvphoid, cell cyclic AMP levels. Both of these histamine activities were reversed by burimamide and metiamide; neither activity was affected by diphenhydramine or pyrilamine. These findings indicate that modulation of effector T cell activity by histamine is mediated only by one of the subtypes of tissue histamine receptors, designated a histamine-type 2 receptor. This receptor appears to be present on cytolytically active cells; there is no evidence for activation by histamine of auxiliary or "suppressor" cells.
The estimated dissociation constant (KB) for the burimamide-receptor complex (9 X 10' M) and for the metiamide-receptor complex (8 X 10-7 M) indicated that the histamine receptor on T cells is quite similar to histamine-type 2 receptors in other tissues. Cells bearing such receptors could not be isolated by passage through a column of histamine-coated Sepharose beads.
The cytolytic activity of spleen cells taken from mice early (days 7-9) after immunization is virtually unaffected by histamine in vitro. In contrast, the activity of spleen cells taken from mice later in the immune response is progressively more susceptible to inhibition lby histamine. After reaching a maximum at day 11, the spleen cell cytolytic activity falls in a pattern that Received for ptublication 3 September 1974 and in revised form 25 Novemiber 1974. parallels the increase in susceptibility to histamine. The susceptibility of effector T cells to histamine appears also to reflect their site of origin, for peritoneal exudate effector cells were found to be significantly less sensitive than spleen cells to inhibition by histamine.
The progressive increase in inhibition by histamine apparently reflects the appearance of greater numbers of specific histamine-type 2 receptors, and is probably a general phenomenon, for spleen cells from A/J or C3H mice immunized with either P815 mastocytoma (H-2d) or EL-4 (H-2b) cells showed the same effect. However, the appearance of histamine receptors could be altered by prior immunization with an unrelated alloantigen: thus, when A/J mice are preimmunized with EL-4, a subsequent immunization with mastocytoma cells results in peak spleen anti-H-2d activity at day 9 instead of days [11] [12] [13] , and the appearance of significant (> 40%) inhibition by histamine as early as day 8 instead of day 16 .
The physiological role of the histamine receptors is as yet undefined, though their unexpected rate of appearance on effector T cells, coincident with a decline in the number of lytically active cells in vivo, may be a significant hint that hormone receptors play a role in the control of T-cell proliferation.
INTRODUCTION by a variety of exogenous hormones (1, 2). These hormones, notably prostaglandins of the F series, epinep)hrine, and histamine, act through pharmacologically specific receptors on the lymphocyte surface. They appear to act through a common pathway: hormonereceptor interaction activates membrane-associated adenlvate cyclase. The resulting increase in cAMP in the effector cell leads to suppression of the cell's lytic activity (1) (2) (3) . Our interest in defining both the nature and role of hormone receptors on lyvmphoid cells has recently centered on histamine, a hormone shown to function through two types of tissue receptors. On pharmacologic grounds, Ash and Schild (4) have demonstrated that one histamine receptor (denoted "histamine-i") is antagonized by 'classical" antihistamines, e.g., diphenhydramine, pyrilamine, and their analogues. It is through such sites that histamine's ability to contract bronchial or ileal smooth muscle is mediated. Histamine-2 receptor sites, on the other hand, mediate gastric acid secretion and atrial rate stimulation. These sites are unaffected by antagonists of the diphenhydramine series, but are specifically antagonized by two recently synthesized thiourea derivatives of histamine, metiamlide and burimamide (5. 6).
Our preliminary studies (7) demonstrated that the histamine-induced inhibition of cvtolysis was antagonized by burimamide and nmetiamide, but not by diphenhydramine or pyrilamine. On shown that the effect of histamine is highly dependent on the immune status of the animal from which the effector cells are derived. When cvtolvtically active cells first appear (day 9), the cells are only minimallv affected b1 histamine, but during the succeeding 7-8 days, the cells become increasingly susceptible to histamine; ultimately histamine can induce a 50% reduction in in vitro cytolytic activity (8) .
The present studies detail several aspects of the developmental patterns of histamine receptors. It appears that histamine inhibition reflects two populations of T cells, one wxith and one wNvithout histamine receptors.
Thus, we propose that early in the immune response, the majority of cytolytically active cells lack histamine receptors. The subsequent appearance of increasing proportions of effector cells bearing histamine receptors would explain the greater ability of histamine to inhibit cytolytic activity. Splenic lymphocyte sutsPctsionzs. Lymphocyte suspensions were prepared as previously described in detail (9) . Briefly, the spleens were removed aseptically into Eagle's suspension culture medium containing 100 U/ml penicillin and 100 lug/ml streptomycin (MEM) and passed through wire gauze grids (mesh size 60, Small Parts, Inc., Miami, Fla.). The cells were centrifuged initially for 8 s at 800 rpm (to remove cell debris) and then washed by centrifuging three times for 5 min at 1,000 rpm in the medium containing 10%0 inactivated fetal bovine serum (MES). The final yield was 1.0-1.5 X 108 cells/spleen with > 90% viability as judged by trypan blue exclusion.
In some experiments, after the first wash in MEMN, red blood cells were lysed by suspending the cell preparations in 0.83%o NH4Cl for 5 min at room temperature (10) . In a few experiments, the erythrocyte-free preparations were further prepared by incubating the cells in glass wool columns (11) Histamine-coated beads. Histamine was conjugated (via 1-ethyl-3-3-dimethyl aminopropyl carbodiimide) to rabbit serum albumin (RSA) ; the histamine-RSA, or, as control, serum albumin alone, were attached to CNBr-activated Sepharose (S) beads (13) . These beads (histamine-conjugated designated H-RSA-S, control designated RSA-S) were independently prepared in two laboratories, and were kindly provided by Drs. Yacob Weinstein, Kenneth Melmon, and Henry Bourne (University of California, San Francisco) and by Dr. Tadamitsu Kishimoto (Johns Hopkins University). The details of preparation are as previously described (13, 14) .
Beads obtained from Dr. Kishimoto were tested for cell binding by a technique analogous to that described by Weinstein, Melmon, Bourne, and Sela (14) . Erythrocytefree splenic lymphocytes (3.3 X 107) plus drug were preincubated in a total volume of 0.5 ml MEM for 10 min at 370C; then 0.5 ml of 50%o H-RSA-S beads in MEM were added and incubation continued an additional 15 min at 370C. Cells were passed through columns (as described below) and the columns washed with two 2-ml portions of MEM containing drug.
In three determinations with two nonimmune spleen cell preparations, with drug-free mixtures of cells + H-RSA-S, 48±5% (SEM) of cells applied were eluted; in the presence of 10' M diphenhydramine, 68±4% of cells were eluted; in the presence of 10' M diphenhydramine (one determination) 38% of cells were eluted.
H-RSA-Sepharose colunmnis. 1 X 108 spleen cell suspensions in 1.2 ml MEM (no serum) were incubated with 1.2 ml of Sepharose suspensions (50%o wt/vol) at 370C for 15 min with intermittent shaking; the cell-free Sepharose mixture was then applied to a plastic column (the lower 3 ml of a 5-ml plastic pipette, with a sponge at the bottom to retain the Sepharose beads) (14) , and the eluate was collected after washing with two 1-ml portions of MEM. The eluted cells were washed twice in MES, counted, and used in cytolytic assays as described below. In general, no attempts were made to recover bound cells.
Target cells (and ininuLvntationi). Mouse mastocytoma cells (P815 of the DBA/2 strain) were maintained in ascitic fluid of adult DBA/2 mice. EL-4 lymphoma cells (derived from C57BL/6 mice) were maintained in ascitic fluid of adult C57BL/6 mice; both were passaged weekly. The Cytolytic assays. These assays were similar to those described previously (9, 15) . Immune lymphocytes were obtained from spleens of donors, generally [10] [11] [12] [13] [14] [15] [16] [17] [18] Inhibition of specific cytolysis by drugs was calculated relative to tubes containing no drugs (2) . Neither histamine nor antihistamines in the concentrations used in these experiments ever affected "spontaneous" 51Cr release (i.e., 21Cr release from target cells in the presence of nonimmune lymphocytes).
The (18) . The specificity of this antiserum for mouse thymocytes has also been previously described (18) . 2 X 107 lymphocytes were incubated in Earle's medium containing glutamine, 100 U/ml penicillin, and 100 /Ag/ml streptomycin (Microbiological Associates)
with a final concentration of 1/33 antiserum, and 1/10 guinea pig serum as complement source, for 30 min at 370C.
The cells were washed three times in MES, counted, and assayed for cytolytic activity. Cyclic AMP assays. These were performed by mixing 1 X 107 lymphocytes from immune or nonimmune C57BL/6 mice in 1 ml MES at 370C; 10-min incubations were used routinely because the maximum change in cAMP induced by histamine was obtained at this time. The cell suspensions were centrifuged at 1,000 rpm for 5 min, and the precipitate was resuspended in 0.5 ml 5% trichloroacetic acid. The suspension was frozen until assayed for cAMP by the method of Brown, Albano, Ekins, and Sgherzi (19) , as previously adapted for the measurement of lymphocyte preparations (2, 7, 20) . These measurements were kindly made by Dr. Elizabeth Gillespie, Johns Hopkins University.
RESULTS
Effect of histamine and antihistamine on cytolytic activity and cAMP levels. Histamine inhibited cytolytic activity and caused an increase in spleen cell cAMP levels. The inhibition by histamine was dosedependent, and was maximal at 10' M; furthermore, it was almost completely reversible. Thus, after a 30-60-min preincubation of lymphocytes with histamine and one wash, the inhibition by histamine was reversed 70-95% (three experiments, data not shown).
Histamine induced increased cyclic AMP levels in whole spleen cell populations, which after 10 min of incubation were 66% above control. After 3 and 6 h the cAMP levels of histamine-stimulated spleen cells returned to base line (data not shown). Corresponding to the temporal sequence of cyclic AMP changes, the inhibition by histamine of cvtolytic activity was constant over assay periods of 1-4 h (data not shown).
Proof that the histamine receptor is pharmacologically specific requires that antihistamines specifically antagonize the histamine effect. In our preliminary report (7) we showed that the histamine-2 antagonist burinmanlide specifically reversed the inhibition by histamlline of cvtolytic activity and also reversed the histamine-induced augmentation of cAMIP levels of nonimmune cell populations. The histamine-2 antagonist metiamide also readily reverses the inhibition of cytolysis due to histamine (Fig. 1B, discussed below) (6) and human basophils (25) . It thus appears that the receptor in mouse effector T cells is quantitatively similar to histamine-2 receptors in other tissues.
Evidence that cells bearing histaminc receptors are effector cells. Although the preceding experiments clearly established that a histamine type-2 receptor was responsible for the inhibition by histamine of in vitro cytolytic activity, they did not define the cell (i.e., effector cell, or some type of "auxiliary" or suppressor cell) upon which the receptors appear. As the cell types cannot be fractionated by columns, the identity of the cells cannot be explored directly. We have attempted a preliminary study of the role of auxiliary cells. The three approaches we have used to suggest that histaminereceptor cells are a part of the cytolytically active cell population include depletion of adherent cells; alteration of the ratio of effector to target cells; and mixture of different effector cell populations.
Ren oval of adherent cells. Preliminary indications that histamine acted directly on effector cells came from the observations that the in vitro susceptibility of cytolytic activity to histamine varied during the immune response (8; see Table V) . To provide more direct evidence for the role of the effector cells them-selves (rather than some other cell) splenic cell preparations were passed through glass wool columns, and the nonadherent cells were elutedl and tested for cvtolytic activity and inhibition by histamine. In a typical experiment, shown in Table II If, on the other hand, the histamine receptors are present on "auxiliary" (noneffector) cells, then alteration of the lymphocyte-target cell ratio conceivably might alter histamine-induced inhibition of cytolvsis (26) .
In experiments designed to test this hypothesis, immune splenic lymphocytes were mixed with target cells at ratios ranging from 100: 1 to 3: 1. (8) on the effect of immunization on histamine receptors, young adult C57BL/6 mice were immunized i.p. with 10' mastocytoma cells, and at intervals from 7-53 days later, spleens were removed and single cell suspensions were assayed for cytolytic activity and inhibition of cytolytic activity by histamine alone or histamine and burimamide. Additionally, the effect of histamine on cAMP levels of splenic cell populations was also determined.
Table V summarizes data from over 90 experiments; some of the data is also depicted graphically in Fig. 3 . In accord with our previous findings, the following points should be noted: (a) Cytolytic activity reached a peak 10-12 days after immunization, and then slowly (2) . These values were subtracted from percent total cytolysis to yield percent specific cytolysis. * The lymphocyte/target cell ratio (L/T ratio) is the ratio of the number of "immune"
lymphocytes to target cells. Although spleen cell cytolytic activity reached a maximum on days 10-12, and then fell, there was a secondary peak of activity on approximately day 27. The secondary peak was associated with a secondary fall in susceptibility of the lymphocytes to histamine: that is, from 46% on day 18 to 32% on day 27 (Table   V) . This secondary fall in histamine receptors was consistently observed, and is best illustrated (Fig. 4) by a series of experiments in which a group of 50 C57BL/6 mice were immunized and tested for up to 53 days. The experiments depicted in Fig. 4 show the relationship between fall in cytolytic activity (days 10-18) and increase in histamine receptors. In these experiments the susceptibility of the lymphocytes to histamine on days 14 Table  IV , for percent specific cytolysis, and for the percent inhibition of specific cytolysis by 10-' M histamine, for days 8-20.
Tlhe developmenit of histamine receptors after alloantigenic stimuilationz. The preceding findings have demonstrated that effector T lymnphocytes from young adult (2-3 nmo) C57BL/6 mice show an increase in the proportion of histamine receptors during the primary immune response. Since hormone receptors in some species nmay diminish during aging (27) , and since cell-nmediated immune responses may also be altered by aging (28, 29) , the effect of aging on histamine receptors was studied in a screening experiment.
Groups of 12 C57BL/6 male mice-infants 4 wk old, v oung adults 8 wk old, and old breeders 6 mio oldwere immunized with 10_ nmastocvtoma cells; and at 10 and 14 days after immunization, the mice were killed, and spleen cells examined for cvtolvtic activity, histamine inhibition, and cAMl\P levels with and without histamine stimulation.
The results (Table VII) (Table   VIII and Fig. 5 ) similar to that of C57BL/6 (Table   V) . When these strains were immunized with EL-4 lymphoma cells, effector cells appeared with a similar pattern of increased susceptibility to histamine, although the histamine receptors on the anti-EL-4 effector cells developed more slowly than in response to the P815 tumor cell antigen (Table VIII and Fig.  5 ). Since burimanlide reversed the histamine effect in all cases, the cells apl)l)eared to dlemonstrate histamine-2 receptors similar to those of C57BL/6 lymphocytes.
Effect of prior immunine stimuttlation on histamine receptors. If the pattern of susceptibility to histamine is entirely invariable, i.e., if antigenic stimuli result in the initial appearance of effector cells with low numbers of histamine receptors, followed by effector cells with increased numbers of histamine receptors, then the pattern of increasing susceptibility to histamine (Tables V and VIII) will be unaffected by prior immunization with an unrelated antigen. On the other hand, since immunization with one antigen on occasion is known to affect by "antigenic competition" (30) the immune response to a second antigen, it was considered possible that the pattern of histamine receptors might be altered by prior immunization.
To test these alternatives, groups of 25 A/J mice were initially immunized i.p. with 1.5 X 107 EL-4 lymphoma cells; 12 days later (day 0) the same mice were reinmmunized with 2.5 X 107 mastocytoma cells (group I). These mice were compared to a group of 25 A/J mice immunized on day 0 with mastocytoma cells but never exposed to EL-4 cells (group II). (Immunization of mice with EL-4 cells resulted in no demonstrable lytic activity towards mastocytoma cells, and immunization with mastocvtoma cells resulted in no activity towards EL-4).
The results (Table IX , which concerns cytolytic activity only against mastocytoma cells) demonstrate three significant features. First, spleens from mice preimmunized with EL-4 and subsequently immunized with P815 mastocytoma cells developed considerably fewer anti-P815 effector cells than spleens of animals immunized with P815 cells alone. Secondly, the antimastocytoma effector cells from the animals preimmunized to EL-4 demonstrated a -distinct pattern of histamine susceptibility. 8 days after challenge with P815, the effector cells from group I mice were readily susceptible to histamine (> 40% inhibition), while the group II mice showed the typical pattern of increasing susceptibility up to day 16. Thirdly, in association with an early appearance of histamine receptors in the group I mice, peak cytolytic activity occurred on day 9 in the group I mice, while peak activity did not appear until days [11] [12] [13] 8, anid significant (> 40% ) inhibition by histamine was demonstrable on day 8 (series A) or day 9 (series B). Furthermore, in both series of exleriments the in vitro c)tolytic activity of spleen cells from doubly immunized animals was inhibited more by histamine than activity of cells from singly immunized animals. In series A, the pattern of inhibition by histamine of effector cells from singly immunized mice was comnparable to that shown in Table IX 44 Groups of 25 A/J mice were immutnized i.p. with 1.5 X 107 EL-4 cells. 12 days later ("day 0"), these animals were "doubly immunized" i.p. with 2.5 X 107 P815 mastocytoma cells. A second group of 25 A/J mice ("singly immUtnized") were given 2.5 X 107 mastocytoma cells on day 0, but had not been previously immunized with EL-4 cells. At intervals from 8 to 16 days later, groups of at least three mice from both the doubly and singly immunized animials were killed and single cell sulspe)lsiosl5 prepared from their spleens.
The indicated number of splenic lymphocytes (either 3.3 X 106 or 1 X 107) were incubated with 105 [5'Cr] 
DISCUSSION
Histamine inhibits T lymphocyte-mediated cytolysis through interaction with a pharmacologically specific histamine-2 receptor. In attempts to characterize the cells bearing histamine receptors, spleen cell populations were passed over histamine-conjugated Sepharose beads.
Although the histamine-coated beads bound a significantly greater fraction of cells than the control columns, the eluted cells were not significantly altered with respect to cytolytic activity. The eluted effector cells unexpectedly demonstrated the same susceptibility to histamine as the original spleen cell population. It would thus appear that the histamine receptors on effector cells do not bind specifically to histaminecoated beads. Since the histamine-albumin bond is via the primary amine of histamine, and because the histamine receptors (type 1 and type 2) both are presumed to bind to the primary amine group (31) , it is likely that the H-RSA-S preparations have lost some of the structural specificity for histamine.
This conclusion is also supported by the recent paper of Mlelmon, Weinstein, Shearer, Bourne, and Bauminger (32) . These authors examined histamine-induced changes in cANIP levels of mouse spleen cell populations, and compared them to spleen cells eluted from H-RSA-S beads. The cAMP levels, both control and after histamine, were lower in the H-RSA-S-excluded cells. However, the spleen cells excluded from H-RSA-S responded to histamine with a percent increase in cAMP similar to that of the unfractionated spleen cells.
In this context, it is of interest to note several reports concerning the immunological effects of histamine-coated beads: specifically, the removal of suppressor cells on H-RSA-S beads (33, 34) , and similarly, termination of tolerance after removal of the cells adherent to H-RSA-S beads (35) . Although the histamine beads are selectively depleting certain cell types, the present paper would strongly suggest that the binding of cells to histamine-coated beads is not through specific histamine-type 2 receptors, but because of another type of interaction (perhaps electrostatic forces, although some evidence seems to be against this interpretation (34) The evidence that the effect being measured is mediated by specific histamine receptors is compelling. The capacity of reversible competitive antagonists to alter the sensitivity of a tissue to an antagonist can be quantitated by determining the apparent dissociation constant, KB, of the receptor-antagonist complex. If KB values for a given competitive antagonist are similar, then the receptors may be assumed to be similar (24 (25) , and similarly, the value of 8 X 10-7 MI for metiamide compares to the value in guinea pig atrium of 9 X 1 I-M, rat uterus of 8 X 10-7 NI (6), and human basophils 3-8 X 1O\ M (25) . We have thus defined a receptor on mouse lymphocytes that is very similar to the histamine-2 receptors on other tissues.
It is apparent that intraperitoneal immunization with allogeneic tumor cells results in cytolytically active splenic lymphocytes which become progressively more susceptible to in vitro inhibition by histamine. This pattern has been confirmed in over a hundred experiments employing several different alloantigens and is present in mice of several ages.
The changing susceptibility of lymphocytes to histamine during the primary immune response confirms that the lymphocyte population and not the target cell is being affected by the drug. We interpret the altered susceptibility to histamine as being due to an increase in histamine-type 2 receptors. Several alternative explanations do. however, deserve consideration. Two of these, altered affinity of histamine receptors and altered histamine metabolism, seem unlikely. At all times after immunization, (a) the dose-response curves for histamine are similar (maximal inhibition at 1O I concentration) (8) ; (b) endogenous histamine release from suspensions of splenic lymphocytes and mastocytoma cells is insignificant during the in vitro assay, and exogenous histamine is not significantly reduced during the assay (data not shown) ; and (c) the reversal by burimamide of histamine inhibition is quantitatively identical (8, and Table V) .
Evaluation of a third possibility, namely that nonfunctional receptor-adenylate cyclase complexes become functional, awaits direct measurements of receptors on effector cells.
The emergence of hormone receptors has previously been shown to occur during the in vitro differentiation of several tissues (36) , including lymphocytes (37 (45) (46) (47) (48) , but in addition the experinments demonstrate a significantly lower susceptibilitv to histamine in exudates than in corresponding spleen cells. These differences may permit use of histamine susceptibility as a marker for regional populations of effector cells.
We must consider two as yet unsolved problems. First, the properties of the cell subpopulations that mediate the histamine effect remain unknown. It is known that, during the course of the primary immune response to alloantigen, cytolytically active cells, although heterogeneously distributed on density gradients, tend to become smaller and denser (49) (50) (51) (52) (Tables V and VIII , Fig.  3) ; in the doubly immunized animials (Table IX, group I), the high degree of histamine-induced inhibition of cytolysis on day 8 is associated with an unusually early fall in cvtolytic activity (after day 9). It is conceivable that histanmine, through its receptor, may have a role in the control of T cell proliferation.
